Magdalena Gąsior

Ms. Magdalena Gąsior

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EMEwelina Młynarska
Ewelina Młynarska
KBKinga Bojdo
Kinga Bojdo
ABAnna Bulicz
Anna Bulicz
HFHanna Frankenstein
Hanna Frankenstein
MGMagdalena Gąsior
Magdalena Gąsior
BFBeata Franczyk
Beata Franczyk
Obesity is a multifactorial chronic disease resulting from complex genetic, molecular, environmental, and behavioral interactions. Its prevalence rises worldwide, affecting cardiovascular, metabolic, oncological, hepatic, respiratory, and skeletal health. Beyond caloric excess, genetic predisposition, epigenetic modifications, gut microbiota dysbiosis, endocrine-disrupting agents, circadian misalignment, and intergenerational and prenatal influences are critical determinants of obesity risk. Core pathophysiological mechanisms include insulin resistance, dyslipidemia, chronic low-grade inflammation, and neuroendocrine dysregulation of appetite and energy balance. These processes are linked to comorbidities such as type 2 diabetes, hypertension, atherosclerosis, fatty liver disease, sleep apnea, osteoporosis, and cancer. Advances in molecular profiling, metabolic phenotyping, and body composition analysis are refining obesity classification and enabling precise risk stratification. Current therapeutic strategies include behavioral interventions addressing stress-related mechanisms, pharmacological therapies such as GLP-1 receptor agonists, emerging gene therapy approaches, and bariatric surgery. Gut-derived hormones (leptin, ghrelin, GLP-1, PYY, CCK) are recognized as pivotal regulators of appetite and weight. Preventive strategies increasingly emphasize circadian alignment, while epigenetic inheritance and prenatal exposures such as maternal obesity or smoking highlight early-life programming in future metabolic health. Additionally, artificial intelligence-based platforms and personalized nutrition provide innovative opportunities for individualized prevention and management. This review synthesizes contemporary evidence on the biological basis, systemic consequences, preventive strategies, and evolving therapeutic modalities of obesity, affirming its recognition as a complex chronic disease requiring personalized, multidisciplinary care.

26 April 2024 in Cells
Verified
Journal Article
Open access
PDF file
PFPiotr Fularski
Piotr Fularski
WCWitold Czarnik
Witold Czarnik
HFHanna Frankenstein
Hanna Frankenstein
MGMagdalena Gąsior
Magdalena Gąsior
EMEwelina Młynarska
Ewelina Młynarska
BFBeata Franczyk
Beata Franczyk
Currently, more and more people are suffering from chronic kidney disease (CKD). It is estimated that CKD affects over 10% of the population worldwide. This is a significant issue, as the kidneys largely contribute to maintaining homeostasis by, among other things, regulating blood pressure, the pH of blood, and the water–electrolyte balance and by eliminating unnecessary metabolic waste products from blood. What is more, this disease does not show any specific symptoms at the beginning. The development of CKD is predisposed by certain conditions, such as diabetes mellitus or hypertension. However, these disorders are not the only factors promoting the onset and progression of CKD. The primary purpose of this review is to examine renin–angiotensin–aldosterone system (RAAS) activity, transforming growth factor-β1 (TGF-β1), vascular calcification (VC), uremic toxins, and hypertension in the context of their impact on the occurrence and the course of CKD. We firmly believe that a deeper comprehension of the cellular and molecular mechanisms underlying CKD can lead to an enhanced understanding of the disease. In the future, this may result in the development of medications targeting specific mechanisms involved in the decline of kidney function. Our paper unveils the selected processes responsible for the deterioration of renal filtration abilities.

Verified
Journal Article
Open access
PDF file
ANAleksandra Nowakowska
Aleksandra Nowakowska
WMWeronika Marcinkowska
Weronika Marcinkowska
FGFilip Gagorowski
Filip Gagorowski
MGMagdalena Gąsior
Magdalena Gąsior
KKKatarzyna Kazimierczuk
Katarzyna Kazimierczuk
APAgnieszka Pięta-Dolińska
Agnieszka Pięta-Dolińska
The incidence of malignancies diagnosed during pregnancy is estimated at 1 in 1000 pregnancies, with cervical cancer being the most common gynecological malignancy in this population. The increasing maternal age and widespread use of prenatal screening contribute to the rising detection rates. Early symptoms of cervical cancer, such as vaginal bleeding or discharge, often mimic normal pregnancy changes, leading to potential delays in diagnosis. Cervical dysplasia, a known precursor of cervical cancer, is closely associated with high-risk HPV infection, which affects approximately 25% of women of reproductive age. Screening using cytology and HPV testing is considered safe and effective during pregnancy in early detection. Colposcopy remains the gold standard in further diagnostics, with targeted biopsy indicated in selected cases. In cases of high-grade lesions (CIN II/III), conservative management is often preferred, as more than 60% of lesions regress postpartum. Invasive cervical cancer diagnosed during pregnancy is rare, with an estimated incidence of 1.4–4.6 per 100,000 pregnancies. Management decisions depend on gestational age, cancer stage, and the patient’s reproductive preference. Chemotherapy can be administered after the first trimester with acceptable maternal and fetal safety profiles. This review presents current evidence on screening, diagnostic pathways, and treatment strategies. It emphasizes the importance of individualized care, multidisciplinary collaboration, and shared decision-making to optimize outcomes for both mother and fetus.

1 December 2025 in Biuletyn Głównej Biblioteki Lekarskiej
Verified
Journal Article
Open access
PDF file
MGMagdalena Gąsior
Magdalena Gąsior
KBKinga Bojdo
Kinga Bojdo
ZDZofia Dąbrowska
Zofia Dąbrowska
HFHanna Frankenstein
Hanna Frankenstein
KKKatarzyna Kazimierczuk
Katarzyna Kazimierczuk
AWAmelia Wardak
Amelia Wardak
Caesarean section is the most commonly performed surgical procedure in women worldwide. One of its long-term complications is isthmocele, a defect in the caesarean section scar, also known as a niche or diverticulum. Despite the lack of clear diagnostic criteria, isthmocele is most often defined as a ≥2 mm depression in the uterine muscle at the site of the caesarean section scar, assessed by transvaginal ultrasound or other imaging techniques. The prevalence of the niche is difficult to estimate and depends on the population, time of assessment and diagnostic method. The aetiology of isthmocele is multifactorial, including abnormal suturing technique, low uterine incision, uterine retroversion, and wound healing disorders. In most women, the changes are asymptomatic, but some report intermenstrual bleeding, pelvic pain, or infertility. The niche may also increase the risk of complications in subsequent pregnancies, such as placenta praevia, placenta accreta spectrum, uterine rupture, or cesarean scar pregnancy. There are no clear guidelines for delivery after caesarean section with isthmocele; decisions are made on an individual basis, based on the thickness of the residual muscle. Surgical treatment-laparoscopic or hysteroscopic-can improve anatomical parameters and clinical symptoms, and modifying the technique of suturing the uterus during caesarean section can reduce the risk of niche formation.

30 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MBMartyna Bukowiec
Martyna Bukowiec
KKKlaudia Korona
Klaudia Korona
MGMagdalena Gąsior
Magdalena Gąsior
JRJagoda Oliwia Rogowska
Jagoda Oliwia Rogowska
MKMichał Kopera
Michał Kopera
Anorexia nervosa is a severe psychiatric disorder characterized by persistent food restriction, distorted body image, and an intense fear of weight gain. It exhibits one of the highest mortality rates among mental illnesses, second only to opioid use disorder. This review synthesizes current evidence on the etiology, diagnosis, comorbidities, and treatment of anorexia nervosa. The multifactorial pathogenesis includes genetic, neurobiological, psychological, and sociocultural components. Diagnostic criteria according to ICD-11 emphasize low body weight and behavioral patterns of restrictive eating. anorexia nervosa frequently coexists with medical complications affecting cardiovascular, gastrointestinal, endocrine, and skeletal systems, which contribute to its high morbidity and mortality. The review evaluates established psychological treatments, and family-based therapy, and highlights the limited and effectiveness of pharmacotherapy, including antidepressants and antipsychotics. Emerging treatments ranging from intranasal oxytocin, cannabinoids, and ketamine to neuromodulatory methods like repetitive transcranial magnetic stimulation and virtual reality therapy show promise, but require further validation. The paper also explores inpatient care, alternative therapies (acupuncture, electroconvulsive therapy), and interventions targeting complications such as bone density loss. Despite significant advancements, relapse rates remain high, and recovery is often incomplete, underscoring the urgent need for individualized, multidisciplinary treatment approaches and further research into mechanism-based and integrative therapies.